Home > Newsletters > FDAnews Drug Daily Bulletin > Contraceptive Sales Could Rise With No-Copay Final Rule
FDAnews Drug Daily Bulletin
Feb. 6, 2012 | Vol. 9 No. 25
Contraceptive Sales Could Rise With No-Copay Final Rule
Contraceptive sales could climb this summer as an HHS final rule requires most health insurance plans to cover preventive services for women, without charging co-pays, beginning Aug. 12. The final rule deviates from an August 11, 2011, interim version by allowing certain religious nonprofits, such as hospitals and universities, an additional year to comply. The change was based on comments to the rule, the department said Jan. 20.
Washington Drug Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.